Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients
about
Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-AnalysisAssessment of treatment response in tuberculosisThe Effectiveness and Safety of Fluoroquinolone-Containing Regimen as a First-Line Treatment for Drug-Sensitive Pulmonary Tuberculosis: A Systematic Review and Meta-AnalysisNew anti-tuberculosis drugs and regimens: 2015 updatePipeline of drugs for related diseases: tuberculosisTuberculosis therapy for 2016 and beyond.Insights into the pharmacokinetic properties of antitubercular drugs.Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.Intermittent Versus Daily Pulmonary Tuberculosis Treatment Regimens: A Meta-Analysis.Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: study protocol for a prospective, multicenter, randomized, open-label, phase II trial.The lack of a big picture in tuberculosis: the clinical point of view, the problems of experimental modeling and immunomodulation. The factors we should consider when designing novel treatment strategies.Therapeutic drug monitoring in the treatment of tuberculosis: an update.Optimizing the clinical pharmacology of tuberculosis medications.Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans.Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models.Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.Fluoroquinolones in the treatment of tuberculosis: which is best?Treatment of Tuberculosis. A Historical Perspective.Tuberculosis updates 2018: Innovations and developments to end TB.Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: Novel insights from the Cornell mouse model.Use of fluoroquinolones for the treatment of TB: 8 years of experience.Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis
P2860
Q26771997-23339359-2E53-4B94-82A0-B7AE975257B2Q26775757-FCB579BF-6D2A-4272-B7E5-C5E8F23ADA47Q28384421-D7FC32A8-8233-4AE9-8E95-9A4E33B25E8BQ28553119-9744CA14-8035-485D-98C3-C1B4E1A1791AQ28596775-F9876A03-285B-4F3B-AA79-7FE09FFA191EQ28818217-4F0C60B2-92C1-49E6-963F-1DC5F4F67D91Q30248788-8FD64945-2432-42C7-8C3A-EF7A1D47BD15Q30251497-A4D475E2-C0FF-4709-A44B-BA339CFD5624Q30275004-6073AA02-A876-424F-AA4E-E8327C5E742FQ33798527-3F659405-D1DE-46E4-B39B-2BCBF3BAA9B9Q35657670-5A86E67E-5755-40A9-B4D6-458E2EF15F04Q36650622-DBD4EC0E-177C-4114-B58C-BB192185BE97Q37640769-FA94F8E1-D317-47A1-A5FE-B9802D4E65F3Q38193087-4D3B5919-E36D-4DE3-82DF-A1DA063EDB83Q38213320-E57DE319-FB89-47EE-8A5E-CCC09DF0B402Q38542159-553A97DA-F0F7-45C8-8389-915C97F3047EQ39398946-253698D3-C638-46B8-9CFD-4D0E7613EFD0Q39456569-0046D649-C320-44DF-844A-EBFEA43E8993Q40087530-40AA39DB-F628-4711-AFC3-224E527A1E61Q40363572-314EC2FB-1255-4615-A699-E676B37BF0FFQ41280396-2A1B0ACC-D246-4236-B07F-B44D55B01907Q42206029-B94FAB3B-8CA4-484A-8704-1E6DCC5C18FFQ44398482-33DB8D8A-2165-47B6-9BF5-73567E96B2ADQ46014832-6AA6BB99-4B3A-4A2E-9C57-FCD0944967DFQ47674177-3D4131D6-D98A-4C35-A36F-5CEEE2C95877Q52584723-93FF5701-A5DD-4B4B-915E-C6EED934FAE7Q53384520-FD4085FB-2A3B-4487-B3B1-202CC97328E1Q57775011-E47AC5C0-4B70-4F8D-AF8C-E8551F5D50D7
P2860
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@ast
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@en
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@nl
type
label
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@ast
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@en
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@nl
prefLabel
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@ast
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@en
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@nl
P2093
P2860
P3181
P1433
P1476
Randomized clinical trial of t ...... ulmonary tuberculosis patients
@en
P2093
Allaudeen S Iliayas
Balambal Raman
Chinnaiyan Ponnuraja
Chinnampedu N Paramasivan
Chockalingam Chandrasekar
Dhanaraj Baskaran
Fathima Rahman
Geetha Shanmugam
Kannivelu Jagannath
Marimuthu M Kumar
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0067030
P407
P577
2013-01-01T00:00:00Z